ZA200707900B - Sublingual coated tablet - Google Patents
Sublingual coated tabletInfo
- Publication number
- ZA200707900B ZA200707900B ZA200707900A ZA200707900A ZA200707900B ZA 200707900 B ZA200707900 B ZA 200707900B ZA 200707900 A ZA200707900 A ZA 200707900A ZA 200707900 A ZA200707900 A ZA 200707900A ZA 200707900 B ZA200707900 B ZA 200707900B
- Authority
- ZA
- South Africa
- Prior art keywords
- coated tablet
- sublingual coated
- sublingual
- tablet
- fentanyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0502727A FR2883179B1 (fr) | 2005-03-18 | 2005-03-18 | Comprime enrobe |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200707900B true ZA200707900B (en) | 2009-01-28 |
Family
ID=35309611
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200707900A ZA200707900B (en) | 2005-03-18 | 2006-03-20 | Sublingual coated tablet |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US8709479B2 (xx) |
| EP (1) | EP1858491B1 (xx) |
| JP (1) | JP5138577B2 (xx) |
| KR (1) | KR101239926B1 (xx) |
| CN (1) | CN101141951B (xx) |
| AT (1) | ATE507824T1 (xx) |
| AU (1) | AU2006224690B2 (xx) |
| BR (1) | BRPI0608505B8 (xx) |
| CA (1) | CA2599502C (xx) |
| CY (1) | CY1111729T1 (xx) |
| DE (1) | DE602006021713D1 (xx) |
| DK (1) | DK1858491T3 (xx) |
| ES (1) | ES2365984T3 (xx) |
| FR (1) | FR2883179B1 (xx) |
| HK (1) | HK1109730A1 (xx) |
| IL (1) | IL185626A (xx) |
| MX (1) | MX2007011440A (xx) |
| NO (1) | NO338771B1 (xx) |
| NZ (1) | NZ561154A (xx) |
| PL (1) | PL1858491T3 (xx) |
| PT (1) | PT1858491E (xx) |
| RU (1) | RU2403043C2 (xx) |
| SI (1) | SI1858491T1 (xx) |
| UA (1) | UA88509C2 (xx) |
| WO (1) | WO2006097361A1 (xx) |
| ZA (1) | ZA200707900B (xx) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1708685B1 (en) * | 2003-12-31 | 2011-03-09 | Cima Labs Inc. | Effervescent oral opiate dosage forms and methods of administering oxycodone |
| FR2883179B1 (fr) | 2005-03-18 | 2009-04-17 | Ethypharm Sa | Comprime enrobe |
| WO2007087452A2 (en) * | 2006-01-27 | 2007-08-02 | Theraquest Biosciences, Llc | Abuse resistant and extended release formulations and method of use thereof |
| US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| US9289583B2 (en) | 2006-01-06 | 2016-03-22 | Acelrx Pharmaceuticals, Inc. | Methods for administering small volume oral transmucosal dosage forms using a dispensing device |
| US8202535B2 (en) * | 2006-01-06 | 2012-06-19 | Acelrx Pharmaceuticals, Inc. | Small-volume oral transmucosal dosage forms |
| US8357114B2 (en) | 2006-01-06 | 2013-01-22 | Acelrx Pharmaceuticals, Inc. | Drug dispensing device with flexible push rod |
| US8252328B2 (en) * | 2006-01-06 | 2012-08-28 | Acelrx Pharmaceuticals, Inc. | Bioadhesive drug formulations for oral transmucosal delivery |
| US9066847B2 (en) | 2007-01-05 | 2015-06-30 | Aceirx Pharmaceuticals, Inc. | Storage and dispensing devices for administration of oral transmucosal dosage forms |
| US8252329B2 (en) | 2007-01-05 | 2012-08-28 | Acelrx Pharmaceuticals, Inc. | Bioadhesive drug formulations for oral transmucosal delivery |
| US8753308B2 (en) | 2006-01-06 | 2014-06-17 | Acelrx Pharmaceuticals, Inc. | Methods for administering small volume oral transmucosal dosage forms using a dispensing device |
| US8865743B2 (en) | 2006-01-06 | 2014-10-21 | Acelrx Pharmaceuticals, Inc. | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
| CN106727271B (zh) * | 2006-01-06 | 2020-02-14 | 阿塞尔Rx制药有限公司 | 小体积口腔经粘膜剂型 |
| US8535714B2 (en) | 2006-01-06 | 2013-09-17 | Acelrx Pharmaceuticals, Inc. | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
| US20070286900A1 (en) * | 2006-06-09 | 2007-12-13 | Catherine Herry | Low dose tablets of opioid analgesics and preparation process |
| US20100233257A1 (en) * | 2006-06-09 | 2010-09-16 | Ethypharm | Low dose sublingual tablets of opioid analgesics and preparation process |
| DE102006054638B4 (de) * | 2006-11-16 | 2014-12-04 | Laburnum Gmbh | Pharmazeutische Einzeldosisform |
| KR101445891B1 (ko) * | 2007-01-05 | 2014-10-02 | 아셀알엑스 파마슈티컬스 인코퍼레이티드 | 경구 경점막 제형의 투여를 위한 저장 및 분배 장치 |
| US20100010031A1 (en) | 2007-02-09 | 2010-01-14 | Yum Ii Su | Transoral dosage forms comprising sufentanil and naloxone |
| CA2704929C (en) * | 2007-08-07 | 2018-05-15 | Pamela Palmer | Compositions and methods for procedural sedation and analgesia using oral transmucosal dosage forms |
| FR2920308B1 (fr) * | 2007-09-05 | 2011-02-25 | Unither Dev | Forme pharmaceutique pour l'administration par voie orale de principes actifs. |
| CA2709905A1 (en) * | 2007-12-17 | 2009-06-25 | Alfred Liang | Abuse-resistant oxycodone composition |
| US20090263476A1 (en) * | 2008-04-16 | 2009-10-22 | Jobdevairakkam Christopher N | Composition of Rapid Disintegrating Direct Compression Buccal Tablet |
| US8945592B2 (en) * | 2008-11-21 | 2015-02-03 | Acelrx Pharmaceuticals, Inc. | Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same |
| US20110097401A1 (en) | 2009-06-12 | 2011-04-28 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
| ES2554626T3 (es) * | 2009-06-12 | 2015-12-22 | Cynapsus Therapeutics Inc. | Apomorfina sublingual |
| US20110091544A1 (en) * | 2009-10-16 | 2011-04-21 | Acelrx Pharmaceuticals, Inc. | Compositions and Methods for Mild Sedation, Anxiolysis and Analgesia in the Procedural Setting |
| US20110288128A1 (en) * | 2010-05-21 | 2011-11-24 | Acelrx Pharmaceuticals, Inc. | Oral Transmucosal Administration of Sufentanil |
| EP2455069A1 (de) * | 2010-11-11 | 2012-05-23 | Laburnum GMBH | Wirkstofffreie Darreichungsform, Verfahren zu deren Herstellung sowie deren Verwendung |
| AU2011346758C1 (en) * | 2010-12-23 | 2015-09-03 | Purdue Pharma L.P. | Tamper resistant solid oral dosage forms |
| MX353623B (es) * | 2011-05-13 | 2018-01-22 | Eb Ip Hybritabs B V | Sistema de suministro de farmaco. |
| CA2834327C (en) | 2011-09-19 | 2017-05-30 | Orexo Ab | New abuse-resistant pharmaceutical composition for the treatment of opioid dependence |
| US8815911B2 (en) | 2012-05-02 | 2014-08-26 | Orexo Ab | Alfentanil composition for the treatment of acute pain |
| CN102755322B (zh) * | 2012-07-24 | 2013-12-11 | 兆科药业（广州）有限公司 | 一种乐卡地平和阿托伐他汀复方制剂 |
| WO2015023675A2 (en) | 2013-08-12 | 2015-02-19 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded immediate release abuse deterrent pill |
| WO2015095391A1 (en) | 2013-12-17 | 2015-06-25 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
| US9492444B2 (en) | 2013-12-17 | 2016-11-15 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
| EP2886103A1 (en) * | 2013-12-23 | 2015-06-24 | Hexal AG | Pharmaceutical orodispersible film comprising buprenorphine particles with a particular size |
| DK3169315T3 (da) | 2014-07-17 | 2020-08-10 | Pharmaceutical Manufacturing Res Services In | Væskefyldt doseringsform til forhindring af misbrug med øjeblikkelig frigivelse |
| US20160106737A1 (en) | 2014-10-20 | 2016-04-21 | Pharmaceutical Manufacturing Research Services, Inc. | Extended Release Abuse Deterrent Liquid Fill Dosage Form |
| EP3578164A1 (en) * | 2018-06-05 | 2019-12-11 | Bio-Gate AG | Thixotropic composition |
| CN209673136U (zh) | 2019-05-07 | 2019-11-22 | 深圳市华普森电子有限公司 | 高清智能一体化管道探测器 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL282752A (xx) * | 1961-09-10 | |||
| US5288498A (en) * | 1985-05-01 | 1994-02-22 | University Of Utah Research Foundation | Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments |
| US4671953A (en) * | 1985-05-01 | 1987-06-09 | University Of Utah Research Foundation | Methods and compositions for noninvasive administration of sedatives, analgesics, and anesthetics |
| JPS6327424A (ja) * | 1986-07-17 | 1988-02-05 | Shionogi & Co Ltd | 徐放性製剤およびその製造法 |
| FR2621483B1 (fr) | 1987-10-08 | 1991-09-20 | Medibrevex | Nouvelles formes galeniques de corticoides pour administration par voie per- et sublinguale et leur procede de preparation |
| US5202128A (en) | 1989-01-06 | 1993-04-13 | F. H. Faulding & Co. Limited | Sustained release pharmaceutical composition |
| US5286493A (en) | 1992-01-27 | 1994-02-15 | Euroceltique, S.A. | Stabilized controlled release formulations having acrylic polymer coating |
| PH30929A (en) | 1992-09-03 | 1997-12-23 | Janssen Pharmaceutica Nv | Beads having a core coated with an antifungal and a polymer. |
| CA2147862A1 (en) * | 1992-11-05 | 1994-05-11 | Robert E. Dempski | Drug delivery device |
| US5411745A (en) | 1994-05-25 | 1995-05-02 | Euro-Celtique, S.A. | Powder-layered morphine sulfate formulations |
| US5744164A (en) | 1994-12-16 | 1998-04-28 | Nestec S.A. | Sustained release microparticulate caffeine formulation |
| US5759577A (en) * | 1995-01-17 | 1998-06-02 | American Home Products Corporation | Controlled release of steroids from sugar coatings |
| FR2771291B1 (fr) | 1997-11-21 | 2000-02-25 | Ethypharm Lab Prod Ethiques | Spheroides, procede de preparation et compositions pharmaceutiques |
| FR2769524B1 (fr) | 1998-01-06 | 1999-12-31 | Ethypharm Lab Prod Ethiques | Dispositif d'enrobage pour granules a absorber par voie orale |
| FR2774910B1 (fr) * | 1998-02-16 | 2001-09-07 | Ethypharm Lab Prod Ethiques | Microgranules de sulfate de morphine, procede de fabrication et preparations pharmaceutiques |
| US6200604B1 (en) | 1998-03-27 | 2001-03-13 | Cima Labs Inc. | Sublingual buccal effervescent |
| ES2157731B1 (es) | 1998-07-21 | 2002-05-01 | Liconsa Liberacion Controlada | Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion. |
| SE9803240D0 (sv) | 1998-09-24 | 1998-09-24 | Diabact Ab | A pharmaceutical composition having a rapid action |
| SE9803239D0 (sv) | 1998-09-24 | 1998-09-24 | Diabact Ab | Composition for the treatment of acute pain |
| US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| US6248760B1 (en) * | 1999-04-14 | 2001-06-19 | Paul C Wilhelmsen | Tablet giving rapid release of nicotine for transmucosal administration |
| US20010016593A1 (en) | 1999-04-14 | 2001-08-23 | Wilhelmsen Paul C. | Element giving rapid release of nicotine for transmucosal administration |
| FR2794646B1 (fr) | 1999-06-09 | 2001-09-21 | Ethypharm Lab Prod Ethiques | Microgranules de sulfate de morphine, procede de preparation et composition les contenant |
| FR2796840B1 (fr) | 1999-07-26 | 2003-06-20 | Ethypharm Lab Prod Ethiques | Comprimes faiblement doses et procede de preparation |
| US6602518B2 (en) * | 2001-06-28 | 2003-08-05 | Wm. Wrigley Jr. Company | Chewable product including active ingredient |
| DE20220910U1 (de) | 2001-08-06 | 2004-08-05 | Euro-Celtique S.A. | Zusammensetzungen zur Verhinderung des Missbrauchs von Opioiden |
| US20030191147A1 (en) | 2002-04-09 | 2003-10-09 | Barry Sherman | Opioid antagonist compositions and dosage forms |
| ES2270335T7 (es) * | 2003-01-31 | 2012-03-16 | Orexo Ab | Composicion farmaceuta de efecto. |
| FR2855756B1 (fr) | 2003-06-06 | 2005-08-26 | Ethypharm Sa | Comprime orodispersible multicouche |
| FR2883179B1 (fr) | 2005-03-18 | 2009-04-17 | Ethypharm Sa | Comprime enrobe |
-
2005
- 2005-03-18 FR FR0502727A patent/FR2883179B1/fr active Active
-
2006
- 2006-03-20 CA CA2599502A patent/CA2599502C/en active Active
- 2006-03-20 CN CN2006800084725A patent/CN101141951B/zh active Active
- 2006-03-20 RU RU2007138647/15A patent/RU2403043C2/ru active
- 2006-03-20 US US11/384,763 patent/US8709479B2/en active Active
- 2006-03-20 SI SI200631068T patent/SI1858491T1/sl unknown
- 2006-03-20 UA UAA200710340A patent/UA88509C2/ru unknown
- 2006-03-20 JP JP2008501248A patent/JP5138577B2/ja active Active
- 2006-03-20 PL PL06724230T patent/PL1858491T3/pl unknown
- 2006-03-20 KR KR1020077021447A patent/KR101239926B1/ko active IP Right Grant
- 2006-03-20 DE DE602006021713T patent/DE602006021713D1/de active Active
- 2006-03-20 EP EP06724230A patent/EP1858491B1/en active Active
- 2006-03-20 AT AT06724230T patent/ATE507824T1/de active
- 2006-03-20 ZA ZA200707900A patent/ZA200707900B/xx unknown
- 2006-03-20 ES ES06724230T patent/ES2365984T3/es active Active
- 2006-03-20 NZ NZ561154A patent/NZ561154A/en unknown
- 2006-03-20 DK DK06724230.5T patent/DK1858491T3/da active
- 2006-03-20 MX MX2007011440A patent/MX2007011440A/es active IP Right Grant
- 2006-03-20 BR BRPI0608505A patent/BRPI0608505B8/pt active IP Right Grant
- 2006-03-20 WO PCT/EP2006/003304 patent/WO2006097361A1/en active Application Filing
- 2006-03-20 AU AU2006224690A patent/AU2006224690B2/en active Active
- 2006-03-20 PT PT06724230T patent/PT1858491E/pt unknown
- 2006-03-20 US US11/909,057 patent/US20080226717A1/en not_active Abandoned
-
2007
- 2007-08-30 IL IL185626A patent/IL185626A/en not_active IP Right Cessation
- 2007-10-18 NO NO20075345A patent/NO338771B1/no not_active Application Discontinuation
-
2008
- 2008-02-27 HK HK08102157.7A patent/HK1109730A1/xx unknown
-
2011
- 2011-08-03 CY CY20111100746T patent/CY1111729T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200707900B (en) | Sublingual coated tablet | |
| TW200617019A (en) | A process for the preparation of 7α-alkylated 19-norsteroids | |
| SG171584A1 (en) | Nanoparticulate metal boride composition and its use for identification- marking plastic parts | |
| HK1163048A1 (en) | Scribe method | |
| MX2008001799A (es) | Composicion farmaceutica que comprende un inhibidor de dipeptidil peptidasa iv. | |
| PL1976521T3 (pl) | Spray fentanylu do podawania podjęzykowego | |
| EP1905430A4 (en) | TABLET | |
| HK1115513A1 (en) | Ornament | |
| IL198845A0 (en) | Sustained-release composition and method for producing the same | |
| EP1775649A4 (en) | PRODUCTION SYSTEM | |
| EP2057985A4 (en) | DRAGEE | |
| GB0424323D0 (en) | Tablet | |
| GB0525021D0 (en) | Coating thickness gauge | |
| DE602006008339D1 (en) | Zolpidemtabletten | |
| EP1766019A4 (en) | MODIFIED PLANT TRANSCRIPTION FACTORS | |
| EP1867324A4 (en) | COMPRESSED | |
| EP2095928A4 (en) | DISC THICKNESS, DISC SUBSTRATE AND METHOD OF FORMING THE DISC SUBSTRATE | |
| EP1920914A4 (en) | DECORATIVE PLATE AND METHOD FOR MANUFACTURING THE SAME | |
| GB0506349D0 (en) | Forming method | |
| IL184372A0 (en) | Method for delivering interferon-?? | |
| AU2006901134A0 (en) | Jewellery set | |
| HU0500004V0 (en) | Punch for gum | |
| GB0525191D0 (en) | Coating thickness gauge | |
| GB0411878D0 (en) | Gas production | |
| ZA200903644B (en) | Sustained-release composition and method for producing the same |